Related references
Note: Only part of the references are listed.2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC
Theresa A. McDonagh et al.
EUROPEAN JOURNAL OF HEART FAILURE (2022)
Different left ventricular remodelling patterns and clinical outcomes between non-ischaemic and ischaemic aetiologies in heart failure patients receiving sacubitril/valsartan treatment
Ying-Hsiang Lee et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2022)
Prevalence and prognostic association of ventricular arrhythmia in non-ischaemic heart failure patients: results from the DANISH trial
Rune Boas et al.
EUROPACE (2021)
Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF
James P. Curtain et al.
EUROPEAN HEART JOURNAL (2021)
What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?
Milton Packer
EUROPEAN HEART JOURNAL (2020)
Sacubitril/Valsartan Therapy Ameliorates Ventricular Tachyarrhythmia Inducibility in a Rabbit Myocardial Infarction Model
Po-Cheng Chang et al.
JOURNAL OF CARDIAC FAILURE (2020)
The Effect of Sacubitril/Valsartan on Device Detected Arrhythmias and Electrical Parameters among Dilated Cardiomyopathy Patients with Reduced Ejection Fraction and Implantable Cardioverter Defibrillator
Vincenzo Russo et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Sacubitrilat reduces pro-arrhythmogenic sarcoplasmic reticulum Ca2+leak in human ventricular cardiomyocytes of patients with end-stage heart failure
Joerg Eiringhaus et al.
ESC HEART FAILURE (2020)
Serum potassium in thePARADIGM-HFtrial
Joao Pedro Ferreira et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Angiotensin receptor-neprilysin inhibitior (thiorphan/irbesartan) decreased ischemia-reperfusion induced ventricular arrhythmias in rat; in vivo study
Takwa Mohammed Abdulsalam et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause A PARADIGM-HF Analysis
Luis E. Rohde et al.
JACC-HEART FAILURE (2020)
Reverse electromechanical modelling of diastolic dysfunction in spontaneous hypertensive rat after sacubitril/valsartan therapy
Yen-Ling Sung et al.
ESC HEART FAILURE (2020)
Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials
Xavier Rossello et al.
CLINICAL RESEARCH IN CARDIOLOGY (2019)
Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction
Pieter Martens et al.
CLINICAL RESEARCH IN CARDIOLOGY (2019)
Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF
Michael R. Zile et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial
Akshay S. Desai et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction
James L. Januzzi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation PRIME Study
Duk-Hyun Kang et al.
CIRCULATION (2019)
Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices
Carlos de Diego et al.
HEART RHYTHM (2018)
Is Sacubitril/Valsartan (Also) an Antiarrhythmic Drug?
Axel Sarrias et al.
CIRCULATION (2018)
Effectiveness of drug interventions to prevent sudden cardiac death in patients with heart failure and reduced ejection fraction: an overview of systematic reviews
Muaamar Al-Gobari et al.
BMJ OPEN (2018)
Sacubitril/Valsartan Averts Adverse Post-Infarction Ventricular Remodeling and Preserves Systolic Function in Rabbits
Juan Torrado et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Declining Risk of Sudden Death in Heart Failure
Li Shen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Single therapeutic and supratherapeutic doses of sacubitril/valsartan (LCZ696) do not affect cardiac repolarization
Thomas H. Langenickel et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure
Lars Kober et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs
John L. Sapp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients
Akshay S. Desai et al.
EUROPEAN HEART JOURNAL (2015)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)
John J. V. McMurray et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
The Effect of Aldosterone Antagonists for Ventricular Arrhythmia: A Meta-Analysis
Jiafu Wei et al.
CLINICAL CARDIOLOGY (2010)
Antiarrhythmic effect of carvedilol after acute myocardial infarction - Results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial
J McMurray et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Dual angiotensin-converting enzyme/neutral endopeptidase inhibition on cardiac and renal fibrosis and inflammation in DOCA-salt hypertensive rats
O Pu et al.
JOURNAL OF HYPERTENSION (2005)
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials
SJ Connolly et al.
EUROPEAN HEART JOURNAL (2000)
Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death
JR Teerlink et al.
CIRCULATION (2000)
Share Paper
